Parkinson's disease, dopamine pathways, movement disorders, and neuroprotection
109 articles
A new Cell Metabolism study reveals how oxidative stress triggers astrocytes to produce collagen, forming barriers that kill neurons after stroke.
A landmark review argues neurodegeneration is driven by interacting misfolded proteins, not single culprits — reshaping diagnosis and treatment.
A new AI classifier using just 15 proteins achieves 95.5% AUC accuracy across Alzheimer's, Parkinson's, FTD, and Lewy body dementia.
NYU professor Scott Galloway and Andrew Huberman unpack what it takes for men to build meaning, health, and economic stability today.
Neuroscientist Dr. Tommy Wood breaks down diet, exercise, supplementation, and cognitive stimulation strategies to protect brain health across your lifespan.
New research links early dopamine neuron dysfunction in the entorhinal cortex to memory loss in Alzheimer's — and L-DOPA reversed it in mice.
First 6-month RCT shows PAP therapy meaningfully improves MoCA scores and motor function in Parkinson's patients with OSA.
New review reveals how protein clumps and cellular powerhouses work together to drive neurodegeneration in Parkinson's disease.
Large international study reveals how current antidepressant use affects brain structure in people with major depression.
NMDA receptor antagonist memantine restored social and recognition memory deficits caused by chronic methamphetamine exposure.
New research shows Hericium erinaceus can force neuroblastoma cells to differentiate into mature neurons while stopping their cancerous growth.
New research maps how genes and environment interact to cause personality disorders, pointing to personalized drug treatments.
